Electromagnetic apparatus for prophylaxis and repair of ophthalmic tissue and method for using same

• US 20080058793A1
• Filed: 06/12/2007
• Published: 03/06/2008
• Est. Priority Date: 06/12/2006
• Status: Abandoned Application

• Current Assignee: Rio Grande Neurosciences, Inc.
• Original Assignee: Rio Grande Neurosciences, Inc.
• Inventors: Dimino, Andre, Pilla, Arthur
• Application Number:
  US11/818,065
• Publication Number:
  US 20080058793A1
• Time in Patent Office: Days
• US Class Current: 606/33
• CPC Class Codes: A61N 1/32 alternating or intermittent currents applying electric fields by inductive or capacitive coupling A61N1/40; microwave apparatus A61N5/02
• CPC Class Codes: A61N 1/326 for promoting growth of cells, e.g. bone cells
• CPC Class Codes: A61N 1/40 Applying electric fields by inductive or capacitive coupling microwave apparatus A61N5/00; Applying radio-frequency signals

Abstract

An apparatus and method for altering the electromagnetic environment of ophthalmic tissues, cells, and molecules comprising, establishing baseline thermal fluctuations in voltage and electrical impedance at a target pathway structure depending on a state of at least one of the ophthalmic tissue components, configuring at least one waveform to have sufficient signal to noise ratio to modulate at least one of ion and ligand interactions whereby the at least one of ion and ligand interactions are detectable in the target pathway structure above the established baseline thermal fluctuations in voltage and electrical impedance, generating an electromagnetic signal from the configured at least one waveform, and coupling the electromagnetic signal to the target pathway structure using a coupling device whereby enhancing the release of second messengers, such as NO, growth factors and cytokines at the target pathway structure. The use of the within specified electromagnetic waveforms can have particular utility in the prophylactic treatment of ophthalmic tissue and the treatment of ophthalmic diseases such as macular degeneration, glaucoma, retinosa pigmentosa, repair and regeneration of optic nerve prophylaxis and other related diseases that respond positively to the physiological effects of these waveforms.

Claims

1. ) An apparatus for altering the electromagnetic environment of ophthalmic tissues, cells, and molecules comprising:

an electromagnetic signal generating means for emitting signals comprising bursts of at least one of sinusoidal, rectangular, chaotic, and random waveforms, having a frequency content in a range of about 0.01 Hz to about 100 MHz at about 1 to about 100,000 waveforms per second, having a burst duration of 1 usec to 100 msec, and having a burst repetition rate from about 0.01 to about 1000 bursts/second, wherein the waveforms are adapted to have sufficient signal to noise ratio in respect of a given target pathway structure to modulate at least one of ion and ligand interactions in that target pathway structure, and

an electromagnetic signal coupling means for delivering the electromagnetic signal to the target pathway structure.

2. ) The apparatus of claim 1, wherein the signals comprise about 0.001 to about 100 msec bursts repeating at about 0.1 to about 10 pulses per second of about 1 to about 100 microsecond rectangular pulses.

3. ) The apparatus of claim 1, configured for providing an emitted signal having a peak signal amplitude at a target pathway structure in a range of about 1 μ

V/cm to about 100 mV/cm.

4. ) The apparatus of claim 1, wherein each signal burst envelope is a random function for providing a means to accommodate different electromagnetic characteristics of healing tissue.

5. ) The apparatus of claim 1, wherein the apparatus is configured for emitting a 20 millisecond pulse burst comprising about 0.1 microsecond to about 20 microsecond at least one of symmetrical and asymmetrical pulses repeating at about 1 to about 100 KHz within the burst.

6. ) The apparatus of claim 1, wherein the apparatus is configured for emitting an about 1 millisecond to an about 5 millisecond burst of 27.12 MHz sinusoidal waves repeating at about 1 to about 100 bursts/sec.

7. ) The apparatus of claim 1, wherein the coupling means is at least one of an inductive coupling means and a capacitive coupling means.

8. ) The apparatus of claim 1, wherein said target pathway structure includes at least one of an ophthalmic molecule, an ophthalmic cell, an ophthalmic tissue, and an ophthalmic organ.

11. ) The apparatus of claim 8, wherein said target pathway structure includes at least one of an ophthalmic molecule, an ophthalmic cell, an ophthalmic tissue, and an ophthalmic organ.

12. ) The apparatus of claim 8, wherein the configuration means includes a configuration means for configuring at least one waveform having at least one of a frequency component parameter that configures said at least one waveform to be between about 0.01 Hz and about 100 MHz, a burst amplitude envelope parameter that follows an arbitrary amplitude function, a burst amplitude envelope parameter that follows a defined amplitude function, a burst width parameter that varies at each repetition according to an arbitrary width function, a burst width parameter that varies at each repetition according to a defined width function, a peak induced electric field parameter varying between about 1 μ

V/cm and about 100 mV/cm in said target pathway structure, and a peak induced magnetic electric field parameter varying between about 1 μ

T and about 0.1 T in said target pathway structure.

13. ) The apparatus of claim 12, wherein said defined amplitude function includes at least one of a 1/frequency function, a logarithmic function, a chaotic function and an exponential function.

14. ) The apparatus of claim 8, wherein the Signal to Noise Ratio includes a Power Signal to Noise Ratio.

15. ) The apparatus of claim 8, wherein said coupling device includes at least one of an inductive generating coupling device, a capacitive generating coupling device, an inductor, and an electrode.

16. ) The apparatus of claim 8, further comprising a positioning device to position the apparatus for delivering electromagnetic signals to at least one of an eye and an area in proximity to an eye.

17. ) The apparatus of claim 16, wherein said positioning device is at least one of an anatomical support, an anatomical wrap, and apparel.

18. ) The apparatus of claim 17, wherein said apparel includes at least one of garments, fashion accessories, eye-patches, eyeglasses, goggles, and monocles.

19. ) The apparatus of claim 8, wherein at least one of said waveform configuration means, connecting means, and coupling device is portable.

20. ) The apparatus of claim 8, wherein at least one of said waveform configuration means, connecting means, and coupling device is disposable.

21. ) The apparatus of claim 8, wherein at least one of said waveform configuration means, connecting means, and coupling device is implantable.

22. ) The apparatus of claim 8, wherein at least one of said waveform configuration means, connecting means, and coupling device is wireless.

9. ) An apparatus for altering the electromagnetic environment of ophthalmic tissues, cells, and molecules comprising:

A waveform configuration means for configuring at least one waveform to have sufficient signal to noise ratio to modulate at least one of ion and ligand interactions whereby the at least one of ion and ligand interactions are detectable in the target pathway structure above baseline thermal fluctuations in voltage and electrical impedance at a target pathway structure; and

A coupling device connected to the waveform configuration means by at least one connecting means for generating an electromagnetic signal from the configured at least one waveform and for coupling the electromagnetic signal to said target pathway structure whereby the at least one of ion and ligand interactions are modulated.

10. ) The apparatus of claim 9, wherein the at least one of ion and ligand interactions includes at least one of calcium ion binding and binding of calcium ions to calmodulin.

23. ) A method for altering the electromagnetic environment of ophthalmic tissues, cells, and molecules comprising:

Establishing baseline thermal fluctuations in voltage and electrical impedance at a target pathway structure depending on a state of the ophthalmic tissue,

Configuring at least one waveform to have sufficient signal to noise ratio to modulate at least one of ion and ligand interactions whereby the at least one of ion and ligand interactions are detectable in the target pathway structure above the established baseline thermal fluctuations in voltage and electrical impedance;

Generating an electromagnetic signal from the configured at least one waveform; and

Coupling the electromagnetic signal to the target pathway structure using a coupling device.

24. ) The method of claim 23, wherein the step of configuring at least one waveform to have sufficient signal to noise ratio to modulate at least one of ion and ligand interactions includes configuring at least one waveform to have sufficient signal to noise ratio to modulate calcium ion binding.

25. ) The method of claim 23, wherein the step of configuring at least one waveform to have sufficient signal to noise ratio to modulate at least one of ion and ligand interactions includes configuring at least one waveform to have sufficient signal to noise ratio to modulate binding of calcium ions to calmodulin.

26. ) The method of claim 23, wherein the step of configuring at least one waveform to have sufficient signal to noise ratio to modulate at least one of ion and ligand interactions includes configuring at least one waveform to have sufficient signal to noise ratio to match a bandpass of a second messenger at a target pathway structure whereby the second messenger modulates biochemical cascades related to tissue growth and repair.

27. ) The method of claim 23, wherein the step of establishing baseline thermal fluctuations in voltage and electrical impedance at a target pathway structure includes establishing baseline thermal fluctuations in voltage and electrical impedance at least one of an ophthalmic molecule, a ophthalmic cell, a ophthalmic tissue, and an ophthalmic organ.

28. ) The method of claim 23, wherein the step of coupling the electromagnetic signal to the target pathway structure using a coupling device includes coupling the electromagnetic signal to the target pathway structure using at least one of an inductive generating coupling device, a capacitive generating coupling device, an inductor, and an electrode.

29. ) The method of claim 23, wherein the step of coupling the electromagnetic signal to the target pathway structure includes coupling the electromagnetic signal to the target pathway structure to enhance the production of second messengers at the target pathway structure.

30. ) The method of claim 29, wherein the step of coupling the electromagnetic signal to the target pathway structure to enhance the production of second messengers at the target pathway structure includes coupling the electromagnetic signal to the target pathway structure to enhance the production of Nitric Oxide at the target pathway structure.

31. ) The method of claim 23, wherein the step of coupling the electromagnetic signal to the target pathway structure includes coupling the electromagnetic signal to the target pathway structure to enhance the production of growth factors at the target pathway structure.

32. ) The method of claim 23, wherein the step of coupling the electromagnetic signal to the target pathway structure includes coupling the electromagnetic signal to the target pathway structure to enhance the production of cytokines at the target pathway structure.

33. ) The method of claim 23, wherein the step of coupling the electromagnetic signal to the target pathway structure includes coupling the electromagnetic signal to the target pathway structure to enhance modulation of binding of at least one of ions and ligands to at least one of regulatory molecules, tissues, cells, and organs.

34. ) The method of claim 23, wherein the step of coupling the electromagnetic signal to the target pathway structure includes coupling the electromagnetic signal to the target pathway structure to provide treatment for at least one of macular degeneration, glaucoma, retinosa pigmentosa, optic nerve prophylaxis, and related ophthalmic diseases.